“…KIDS patients also have recurrent cutaneous infections that can lead to lethal septicemia in pediatric patients, particularly those carrying the Cx26-G45E mutation (Janecke et al , 2005; Griffith et al , 2006; Jonard et al , 2008; Sbidian et al , 2010; Koppelhus et al , 2011). The phenotypic spectrum of KIDS is broad and may also include features of a follicular occlusion triad encompassing dissecting folliculitis, hidradenitis suppurativa, and cystic acne (Montgomery et al , 2004; Maintz et al , 2005), mucositis (Brown et al , 2003; Lazic et al , 2008), or KIDS with proliferative pilar cysts (Nyquist et al , 2007). Current treatment of KIDS is symptomatic and aims to alleviate symptoms, and includes topical or systemic antibiotics/antifungals, keratolytics, and moisturizers (Richard, 2005; Abdollahi et al , 2007; Braun-Falco, 2009).…”